These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 30080045)

  • 1. Discovery of Novel Aminotetralines and Aminochromanes as Selective and Competitive Glycine Transporter 1 (GlyT1) Inhibitors.
    Amberg W; Lange UEW; Ochse M; Pohlki F; Behl B; Relo AL; Hornberger W; Hoft C; Mezler M; Sydor J; Wang Y; Zhao H; Brewer JT; Dietrich J; Li H; Akritopoulou-Zanze I; Lao Y; Hannick SM; Ku YY; Vasudevan A
    J Med Chem; 2018 Sep; 61(17):7503-7524. PubMed ID: 30080045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De Novo Design, Synthesis, and Biological Evaluation of 3,4-Disubstituted Pyrrolidine Sulfonamides as Potent and Selective Glycine Transporter 1 Competitive Inhibitors.
    Wang Y; Zhao H; Brewer JT; Li H; Lao Y; Amberg W; Behl B; Akritopoulou-Zanze I; Dietrich J; Lange UEW; Pohlki F; Hoft C; Hornberger W; Djuric SW; Sydor J; Mezler M; Relo AL; Vasudevan A
    J Med Chem; 2018 Sep; 61(17):7486-7502. PubMed ID: 29969029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitors of GlyT1 affect glycine transport via discrete binding sites.
    Mezler M; Hornberger W; Mueller R; Schmidt M; Amberg W; Braje W; Ochse M; Schoemaker H; Behl B
    Mol Pharmacol; 2008 Dec; 74(6):1705-15. PubMed ID: 18815213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel radioligand for glycine transporter 1: characterization and use in autoradiographic and in vivo brain occupancy studies.
    Zeng Z; O'Brien JA; Lemaire W; O'Malley SS; Miller PJ; Zhao Z; Wallace MA; Raab C; Lindsley CW; Sur C; Williams DL
    Nucl Med Biol; 2008 Apr; 35(3):315-25. PubMed ID: 18355687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological evaluation of a novel assay for detecting glycine transporter 1 inhibitors and their antipsychotic potential.
    Alberati D; Moreau JL; Mory R; Pinard E; Wettstein JG
    Pharmacol Biochem Behav; 2010 Dec; 97(2):185-91. PubMed ID: 20678516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycine transporter (GlyT1) inhibitors with reduced residence time increase prepulse inhibition without inducing hyperlocomotion in DBA/2 mice.
    Kopec K; Flood DG; Gasior M; McKenna BA; Zuvich E; Schreiber J; Salvino JM; Durkin JT; Ator MA; Marino MJ
    Biochem Pharmacol; 2010 Nov; 80(9):1407-17. PubMed ID: 20637735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of the strychnine-sensitive glycine receptor in the anxiolytic effects of GlyT1 inhibitors on maternal separation-induced ultrasonic vocalization in rat pups.
    Komatsu H; Furuya Y; Sawada K; Asada T
    Eur J Pharmacol; 2015 Jan; 746():252-7. PubMed ID: 25435080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective GlyT1 inhibitors: discovery of [4-(3-fluoro-5-trifluoromethylpyridin-2-yl)piperazin-1-yl][5-methanesulfonyl-2-((S)-2,2,2-trifluoro-1-methylethoxy)phenyl]methanone (RG1678), a promising novel medicine to treat schizophrenia.
    Pinard E; Alanine A; Alberati D; Bender M; Borroni E; Bourdeaux P; Brom V; Burner S; Fischer H; Hainzl D; Halm R; Hauser N; Jolidon S; Lengyel J; Marty HP; Meyer T; Moreau JL; Mory R; Narquizian R; Nettekoven M; Norcross RD; Puellmann B; Schmid P; Schmitt S; Stalder H; Wermuth R; Wettstein JG; Zimmerli D
    J Med Chem; 2010 Jun; 53(12):4603-14. PubMed ID: 20491477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of N-(2-(azepan-1-yl)-2-phenylethyl)-benzenesulfonamides as novel inhibitors of GlyT1.
    Varnes JG; Forst JM; Hoerter TN; Holmquist CR; Wilkins DE; Tian G; Jonak G; Wang X; Potts WM; Wood MW; Alhambra C; Brugel TA; Albert JS
    Bioorg Med Chem Lett; 2010 Aug; 20(16):4878-81. PubMed ID: 20637614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of (4H-1,2,4-triazol-4-yl)isoquinoline derivatives as selective glycine transporter 1 inhibitors.
    Sugane T; Tobe T; Hamaguchi W; Shimada I; Maeno K; Miyata J; Suzuki T; Kimizuka T; Morita T; Sakamoto S; Tsukamoto S
    Bioorg Med Chem; 2012 Jan; 20(1):34-41. PubMed ID: 22177408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurochemical and behavioral profiling of the selective GlyT1 inhibitors ALX5407 and LY2365109 indicate a preferential action in caudal vs. cortical brain areas.
    Perry KW; Falcone JF; Fell MJ; Ryder JW; Yu H; Love PL; Katner J; Gordon KD; Wade MR; Man T; Nomikos GG; Phebus LA; Cauvin AJ; Johnson KW; Jones CK; Hoffmann BJ; Sandusky GE; Walter MW; Porter WJ; Yang L; Merchant KM; Shannon HE; Svensson KA
    Neuropharmacology; 2008 Oct; 55(5):743-54. PubMed ID: 18602930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of 3-biphenyl-4-yl-4-phenyl-4H-1,2,4-triazoles as novel glycine transporter 1 inhibitors.
    Sugane T; Tobe T; Hamaguchi W; Shimada I; Maeno K; Miyata J; Suzuki T; Kimizuka T; Kohara A; Morita T; Doihara H; Saita K; Aota M; Furutani M; Shimada Y; Hamada N; Sakamoto S; Tsukamoto S
    J Med Chem; 2011 Jan; 54(1):387-91. PubMed ID: 21141920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and Synthesis of Novel and Selective Glycine Transporter-1 (GlyT1) Inhibitors with Memory Enhancing Properties.
    Santora VJ; Almos TA; Barido R; Basinger J; Bellows CL; Bookser BC; Breitenbucher JG; Broadbent NJ; Cabebe C; Chai CK; Chen M; Chow S; Chung M; Crickard L; Danks AM; Freestone GC; Gitnick D; Gupta V; Hoffmaster C; Hudson AR; Kaplan AP; Kennedy MR; Lee D; Limberis J; Ly K; Mak CC; Masatsugu B; Morse AC; Na J; Neul D; Nikpur J; Peters M; Petroski RE; Renick J; Sebring K; Sevidal S; Tabatabaei A; Wen J; Yan Y; Yoder ZW; Zook D
    J Med Chem; 2018 Jul; 61(14):6018-6033. PubMed ID: 29886732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The discovery of a structurally novel class of inhibitors of the type 1 glycine transporter.
    Lowe JA; Hou X; Schmidt C; David Tingley F; McHardy S; Kalman M; Deninno S; Sanner M; Ward K; Lebel L; Tunucci D; Valentine J; Bronk BS; Schaeffer E
    Bioorg Med Chem Lett; 2009 Jun; 19(11):2974-6. PubMed ID: 19410451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery and SAR studies of novel GlyT1 inhibitors.
    Walter MW; Hoffman BJ; Gordon K; Johnson K; Love P; Jones M; Man T; Phebus L; Reel JK; Rudyk HC; Shannon H; Svensson K; Yu H; Valli MJ; Porter WJ
    Bioorg Med Chem Lett; 2007 Sep; 17(18):5233-8. PubMed ID: 17629697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between glycine transporter 1 occupancy and the effects of the glycine transporter 1 inhibitor RG1678 or ORG25935 on object retrieval performance in scopolamine impaired rhesus monkey.
    Eddins D; Hamill TG; Puri V; Cannon CE; Vivian JA; Sanabria-Bohórquez SM; Cook JJ; Morrow JA; Thomson F; Uslaner JM
    Psychopharmacology (Berl); 2014 Feb; 231(3):511-9. PubMed ID: 24051602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of GlyT1 inhibitors with improved pharmacokinetic properties.
    Wolkenberg SE; Zhao Z; Wisnoski DD; Leister WH; O'Brien J; Lemaire W; Williams DL; Jacobson MA; Sur C; Kinney GG; Pettibone DJ; Tiller PR; Smith S; Gibson C; Ma BK; Polsky-Fisher SL; Lindsley CW; Hartman GD
    Bioorg Med Chem Lett; 2009 Mar; 19(5):1492-5. PubMed ID: 19181525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and evaluation of [11C]GSK931145 as a novel ligand for imaging the type 1 glycine transporter with positron emission tomography.
    Passchier J; Gentile G; Porter R; Herdon H; Salinas C; Jakobsen S; Audrain H; Laruelle M; Gunn RN
    Synapse; 2010 Jul; 64(7):542-9. PubMed ID: 20196141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurochemical, electrophysiological and pharmacological profiles of the selective inhibitor of the glycine transporter-1 SSR504734, a potential new type of antipsychotic.
    Depoortère R; Dargazanli G; Estenne-Bouhtou G; Coste A; Lanneau C; Desvignes C; Poncelet M; Heaulme M; Santucci V; Decobert M; Cudennec A; Voltz C; Boulay D; Terranova JP; Stemmelin J; Roger P; Marabout B; Sevrin M; Vigé X; Biton B; Steinberg R; Françon D; Alonso R; Avenet P; Oury-Donat F; Perrault G; Griebel G; George P; Soubrié P; Scatton B
    Neuropsychopharmacology; 2005 Nov; 30(11):1963-85. PubMed ID: 15956994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-Related Target Occupancy and Effects on Circuitry, Behavior, and Neuroplasticity of the Glycine Transporter-1 Inhibitor PF-03463275 in Healthy and Schizophrenia Subjects.
    D'Souza DC; Carson RE; Driesen N; Johannesen J; Ranganathan M; Krystal JH;
    Biol Psychiatry; 2018 Sep; 84(6):413-421. PubMed ID: 29499855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.